WAGM-TV on MSN3d
Attorney General Aaron M. Frey Announces Settlement Agreement Will Bring $35 Insulin to Mainers
Attorney General Aaron M. Frey announced a settlement agreement with Sanofi-Aventis U.S. LLC after scrutiny over the ...
Maine announces settlement to reduce insulin costs
Under the settlement, Mainers who are uninsured or have commercial health insurance will be eligible to purchase monthly ...
pharmaphorum2d
Civica plans shake-up of insulin sector with low-cost biosimilars
The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo Nordisk's Novolog (insulin aspart) and Eli Lilly's Humalog (insulin lispro) – will be priced at no ...
pharmaphorum2d
First biosimilar fast-acting insulin reaches US market
Before Merilog, the FDA has given the go-ahead to two biosimilars of Sanofi's basal insulin product Lantus (insulin glargine) – Viatris' Semglee and Eli Lilly's Rezvoglar – which are used to ...
Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...